interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Relugolix

Generic competition · all medicines · read 12 November 2026

Is there a generic of Relugolix, and who makes it?

Relugolix appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Relugolix1 dosage-form group in the Orange Book
0generic makers listed
  1. Relugolix appears in 1 dosage-form group in the FDA Orange Book as of 12 November 2026, with no generic maker listed as marketed.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Tablet, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Orgovyx. No generic is listed as marketed.

2020202520302035204001brand 2020data datePatent 7300935 listed to expire 28 January 2029Patent 11795178 listed to expire 27 September 2033Patent 12325714 listed to expire 27 September 2033Patent 10350170 listed to expire 25 February 2036Patent 12144809 listed to expire 29 September 2037Patent 11583526 listed to expire 29 September 2037Patent 12336990 listed to expire 29 September 2037Patent 12097198 listed to expire 29 September 2037Patent 10449191 listed to expire 29 September 2037Patent 10786501 listed to expire 29 September 2037Patent 12629370 listed to expire 29 September 2037
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 28 January 2029Patent 7300935 drug substance
  • 27 September 2033Patent 11795178 drug substance
  • 27 September 2033Patent 12325714 drug substance
  • 25 February 2036Patent 10350170 drug product
  • 29 September 2037Patent 12144809
  • 29 September 2037Patent 11583526
  • 29 September 2037Patent 12336990
  • 29 September 2037Patent 12097198

3 more patents are listed.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.